AR004181A1 - THE USE OF GREEN PORPHYRINS TO PREPARE A PHARMACEUTICAL COMPOSITION TO TREAT ENDOMETRICAL DISORDERS OR FOR THE STERILIZATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. - Google Patents

THE USE OF GREEN PORPHYRINS TO PREPARE A PHARMACEUTICAL COMPOSITION TO TREAT ENDOMETRICAL DISORDERS OR FOR THE STERILIZATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Info

Publication number
AR004181A1
AR004181A1 ARP960103988A AR10398896A AR004181A1 AR 004181 A1 AR004181 A1 AR 004181A1 AR P960103988 A ARP960103988 A AR P960103988A AR 10398896 A AR10398896 A AR 10398896A AR 004181 A1 AR004181 A1 AR 004181A1
Authority
AR
Argentina
Prior art keywords
sterilization
disorders
pharmaceutical composition
prepare
endometrical
Prior art date
Application number
ARP960103988A
Other languages
Spanish (es)
Original Assignee
Universyti Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universyti Of California filed Critical Universyti Of California
Publication of AR004181A1 publication Critical patent/AR004181A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención describe el uso de porfirinas verdes para preparar una composición farmacéutica para tratar desórdenes del endometrio o para laesterilización. Este uso es útil para tratar los desórdenes endometriales como por ejemplo, el sangrado disfuncional uterino, la menorragia, endometriosis yneoplasia endometrial. Otras aplicaciones del método son para la esterilización e interrupción del embarazo temprano. Además se describe una composiciónfarmacéutica que contienen dichas porfirinas verdes.The invention describes the use of green porphyrins to prepare a pharmaceutical composition for treating endometrial disorders or for sterilization. This use is useful for treating endometrial disorders such as dysfunctional uterine bleeding, menorrhagia, endometriosis, and endometrial neoplasia. Other applications of the method are for sterilization and termination of early pregnancy. Furthermore, a pharmaceutical composition containing said green porphyrins is described.

ARP960103988A 1995-08-14 1996-08-14 THE USE OF GREEN PORPHYRINS TO PREPARE A PHARMACEUTICAL COMPOSITION TO TREAT ENDOMETRICAL DISORDERS OR FOR THE STERILIZATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. AR004181A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US227695P 1995-08-14 1995-08-14

Publications (1)

Publication Number Publication Date
AR004181A1 true AR004181A1 (en) 1998-11-04

Family

ID=21700029

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103988A AR004181A1 (en) 1995-08-14 1996-08-14 THE USE OF GREEN PORPHYRINS TO PREPARE A PHARMACEUTICAL COMPOSITION TO TREAT ENDOMETRICAL DISORDERS OR FOR THE STERILIZATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Country Status (7)

Country Link
EP (1) EP0844876A4 (en)
JP (1) JP2000502044A (en)
AR (1) AR004181A1 (en)
AU (1) AU6692396A (en)
CA (1) CA2229662A1 (en)
WO (1) WO1997006797A1 (en)
ZA (1) ZA966833B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010257753B2 (en) * 2009-06-11 2014-09-18 Photocure Asa Semi-solid compositions and pharmaceutical products
RU2714599C1 (en) * 2018-12-26 2020-02-18 Министерство науки и высшего образования Российской Федерации Федеральное государственное бюджетное учреждение здравоохранения Центральная клиническая больница Российской академии наук (ЦКБ РАН) Method of infertility treatment in patients with chronic endometritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors

Also Published As

Publication number Publication date
ZA966833B (en) 1997-02-27
JP2000502044A (en) 2000-02-22
EP0844876A4 (en) 1999-12-01
EP0844876A1 (en) 1998-06-03
AU6692396A (en) 1997-03-12
CA2229662A1 (en) 1997-02-27
WO1997006797A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
AR020055A1 (en) A PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A SUBSTANCE OF ACTIVE ENAMEL, USES OF SUCH COMPOSITION AND A METHOD TO PREPARE THE SAME.
MX9306133A (en) COMPOSITION THAT INCLUDES A FORMULATION OF THE COAGULATION FACTOR VIII, PROCESS FOR ITS PREPARATION AND USE OF A SURFACTANT AS A STABILIZER.
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
GT199800158AA (en) PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS
DE60117043D1 (en) TREATMENT OF MUCOSITIS
MX9206315A (en) RECOMBINANT HETERODIMERS OF MORPHOGENIC BONE PROTEINS, COMPOSITIONS OF THESE AND METHODS FOR USE.
ES2159382T3 (en) STILBENIC COMPOUNDS WITH ADAMANTILO GROUP, COMPOSITIONS THAT CONTAIN THEM AND USES.
AR003220A1 (en) ACILATED MELATONIN DERIVATIVES; PHARMACEUTICAL AND COSMETIC COMPOSITION AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
AR005987A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
BR0100046A (en) Water-soluble or water-swellable cross-linked copolymers
MX167917B (en) NEW MATERIALS AND SURGICAL DEVICES
DE60214179D1 (en) IMIDAZOi1,2-AOPYRIDINE DERIVATIVES FOR PROPHYLAXIS AND TREATMENT OF HERPES INFECTIONS
CY1105125T1 (en) USE OF ACETYLCHOLINESTEPASE INHIBITORS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE THERAPEUTIC TREATMENT OF FUNCTIONAL AND/OR ORGANIC PAIN SYNDROMES
MX9300407A (en) AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION.
AR031975A1 (en) ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM
ATE235907T1 (en) USE OF COMPETITIVE PROGESTERONE ANTAGONISTS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF DYSFUNCTIONAL UTERINE BLEEDING
ATE220918T1 (en) COMPOSITIONS CONTAINING MATRIX PROTEIN FOR WOUND HEALING
ES2157524T3 (en) DISELENUROS AND SELENOSULFURES USED AS ANTIOXIDANT AGENTS.
AR021843A1 (en) DERIVATIVES OF PROPANOLAMINE SUBSTITUTED WITH HETEROCICLES, PROCEDURE FOR THEIR PREPARATION, AND ITS USE.
ES507810A0 (en) PROCEDURE FOR HYDROFORMILAR OLEPHINICALLY UNSATURATED COMPOUNDS.
ES2032339T3 (en) PROCEDURE FOR PREPARING NEW INDOLYLPIPERIDINE COMPOUNDS.
AR004181A1 (en) THE USE OF GREEN PORPHYRINS TO PREPARE A PHARMACEUTICAL COMPOSITION TO TREAT ENDOMETRICAL DISORDERS OR FOR THE STERILIZATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE107859T1 (en) USE OF ANTIPROGESTOMIMETICS TO STIMULATE OVULATION.
AR001813A1 (en) Chromone derivatives procedure for preparing them and the pharmaceutical compositions containing them
ES2177811T3 (en) USE OF NITROFLAVONOIDS FOR THE TREATMENT OF ANXIETY.